Bahram Delfan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bahram Delfan has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Mahmoud Bahmani
Biotechnology and Medicinal Plants Research Center, Ilam University of Medical Sciences, Ilam, Iran
7 shared publications - Ahmad Reza Dehpour
Experimental Medicine Research Center, Tehran University of Medical Sciences
6 shared publications Kourosh Saki
5 shared publications- Mahmoud Rafieian-Kopaei
Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran
5 shared publications Marzieh Rashidipour
Environmental Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran
4 shared publications- Behrouz Ezatpour
Lorestan University of Medical Sciences
3 shared publications
Latest Publications
- Open Access
- 9 June 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85  (7) , 3482-3490
Difference of cardiac rehabilitation in the morning or evening on indexes of left ventricular and N-terminal pro-brain natriuretic peptide: a randomized controlled trial
Background: The present study aimed to evaluate the effects a cardiac rehabilitation program (CRP) performed in the morning or evening on left ventricular (LV) filling indices and the level of N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) in patients undergoing percutaneous coronary angioplasty during the COVID-19 pandemic. Methods: This was a randomized controlled single-blinded clinical trial. Ninety-six patients (mean age: 50.2 ± 8.1 years, 36 women and 44 men) with percutaneous coronary angioplasty were divided into two groups of intervention and control. In each group, the CRP was performed in either morning or evening. The CRP included walking and performing push-ups and sit-ups for 8 weeks. The participants of the control groups received routine care. The functional indices of LV, including LV ejection fraction, systolic function, and diastolic function (i.e. the transmitral flow), the E/e’ to left atrium peak strain ratio (as an estimation for LA stiffness), and NT-proBNP level were measured in all participants before starting and at the end of the CRP. Results: In the intervention group, the individuals performing the CRP in the evening had significantly higher E-wave (0.76±0.02 vs. 0.75±0.03; P=0.008), ejection fraction (52.5±5.64 vs. 55.5±3.59; P=0.011), and diastolic function velocity (E/A ratio, 1.03±0.06 vs. 1.05±0.03; P=0.014) and significantly lower A-wave (0.72±0.02 vs. 0.71±0.01; P=0.041), E/e’ ratio (6.74±0.29 vs. 6.51±0.38; P=0.038), and NT-proBNP level (2007.9±214.24 vs. 1933.9±253.13; P=0.045) compared with those performing the program in the morning. Conclusions: A supervised CRP performed in the evening compared with morning was more effective in improving LV functional indices. Therefore, such home-based interventions are recommended to be performed in the evening during the COVID-19 pandemic.
- 9 June 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85  (7) , 3482-3490
Open AccessDifference of cardiac rehabilitation in the morning or evening on indexes of left ventricular and N-terminal pro-brain natriuretic peptide: a randomized controlled trial
Background: The present study aimed to evaluate the effects a cardiac rehabilitation program (CRP) performed in the morning or evening on left ventricular (LV) filling indices and the level of N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) in patients undergoing percutaneous coronary angioplasty during the COVID-19 pandemic. Methods: This was a randomized controlled single-blinded clinical trial. Ninety-six patients (mean age: 50.2 ± 8.1 years, 36 women and 44 men) with percutaneous coronary angioplasty were divided into two groups of intervention and control. In each group, the CRP was performed in either morning or evening. The CRP included walking and performing push-ups and sit-ups for 8 weeks. The participants of the control groups received routine care. The functional indices of LV, including LV ejection fraction, systolic function, and diastolic function (i.e. the transmitral flow), the E/e’ to left atrium peak strain ratio (as an estimation for LA stiffness), and NT-proBNP level were measured in all participants before starting and at the end of the CRP. Results: In the intervention group, the individuals performing the CRP in the evening had significantly higher E-wave (0.76±0.02 vs. 0.75±0.03; P=0.008), ejection fraction (52.5±5.64 vs. 55.5±3.59; P=0.011), and diastolic function velocity (E/A ratio, 1.03±0.06 vs. 1.05±0.03; P=0.014) and significantly lower A-wave (0.72±0.02 vs. 0.71±0.01; P=0.041), E/e’ ratio (6.74±0.29 vs. 6.51±0.38; P=0.038), and NT-proBNP level (2007.9±214.24 vs. 1933.9±253.13; P=0.045) compared with those performing the program in the morning. Conclusions: A supervised CRP performed in the evening compared with morning was more effective in improving LV functional indices. Therefore, such home-based interventions are recommended to be performed in the evening during the COVID-19 pandemic.
- Open Access
- 3 October 2017
- Published by Marmara University in Marmara Pharmaceutical Journal
- Vol. 4  (21) , 837-842
The therapeutic effects of olive leaf extract on Leishmania major infection in BALB/c mice
At present, no effective vaccine has been found for CL; thus, the upgrading and improvement of the present drugs and development of the novel agents have been demonstrated to be the merely control choice for this disease. The present study aims to evaluate the effects of olive leaf extract (Olea europaea L. OLE) on Leishmania major infection in BALB/c mice. OLE tested on cutaneous leishmaniasis (CL) in male BALB/c mice with L. major promastigotes (MRHO/IR/75/ER) at the doses of 10, 20, and 30 mg/kg. Results demonstrated that after treatment of the groups with the concentrations of 10, 20, and 40 mg/ kg of OLE, mean diameter of lesions was reduced by 2.16, 5.87, and 7.61 cm, respectively. Moreover, after 4 weeks of treatment, 83.3%, 66.64%, and 33.32% recovery was observed in the infected mice treated with 40, 20, and 10 mg/kg of OLE, respectively. In conclusion, the present study showed OLE has potent therapeutic effects on cutaneous leishmaniasis.
- 3 October 2017
- Published by Marmara University in Marmara Pharmaceutical Journal
- Vol. 4  (21) , 837-842
Open AccessThe therapeutic effects of olive leaf extract on Leishmania major infection in BALB/c mice
At present, no effective vaccine has been found for CL; thus, the upgrading and improvement of the present drugs and development of the novel agents have been demonstrated to be the merely control choice for this disease. The present study aims to evaluate the effects of olive leaf extract (Olea europaea L. OLE) on Leishmania major infection in BALB/c mice. OLE tested on cutaneous leishmaniasis (CL) in male BALB/c mice with L. major promastigotes (MRHO/IR/75/ER) at the doses of 10, 20, and 30 mg/kg. Results demonstrated that after treatment of the groups with the concentrations of 10, 20, and 40 mg/ kg of OLE, mean diameter of lesions was reduced by 2.16, 5.87, and 7.61 cm, respectively. Moreover, after 4 weeks of treatment, 83.3%, 66.64%, and 33.32% recovery was observed in the infected mice treated with 40, 20, and 10 mg/kg of OLE, respectively. In conclusion, the present study showed OLE has potent therapeutic effects on cutaneous leishmaniasis.
- Open Access
- 1 September 2016
- Published by Elsevier in The Journal of Physiological Sciences
- Vol. 66  (5) , 397-405
Neuroprotective effects of oleuropein against cognitive dysfunction induced by colchicine in hippocampal CA1 area in rats
- 1 September 2016
- Published by Elsevier in The Journal of Physiological Sciences
- Vol. 66  (5) , 397-405
Open AccessNeuroprotective effects of oleuropein against cognitive dysfunction induced by colchicine in hippocampal CA1 area in rats
- 1 August 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 82, 208-215
Antileishmanial, antioxidant, and cytotoxic activities of Quercus infectoria Olivier extract
- 1 August 2016
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 82, 208-215
Antileishmanial, antioxidant, and cytotoxic activities of Quercus infectoria Olivier extract
- 18 February 2016
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 25  (4) , 769-789
Synthesis, crystal structure, biological evaluation, electronic aspects of hydrogen bonds, and QSAR studies of some new N-(substituted phenylurea) diazaphosphore derivatives as anticancer agents
- 18 February 2016
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 25  (4) , 769-789
Synthesis, crystal structure, biological evaluation, electronic aspects of hydrogen bonds, and QSAR studies of some new N-(substituted phenylurea) diazaphosphore derivatives as anticancer agents
- 18 August 2015
- Vol. 8  (4) , 681-684
Cirrhosis-induced morphological changes in the retina: possible role of endogenous opioid
AIM: To investigate the impact of cirrhosis on retinal morphology and to evaluate the role of endogenous opioids as a mediator in cirrhosis induced retinal change. METHODS: Thirty -six male rats were divided into 3 main groups; the common bile duct ligated (BDL) group, the sham -operated (Sham) group and the unoperated (Unop) group. Then each of these three main groups was divided into two subgroups; the first subgroup received daily injection of naltrexone hydrochloride (NIX) and the second group was injected with normal saline (Saline) daily. After 28d, rats were anesthetized and their right eyes were enucleated and assessed for histological changes. The thickness of the rod and cons layer, outer nuclear layer, outer plexiform layer, inner nuclear layer, Inner plexiform layer and ganglion cell layer for each eye were measured in micrometers by light microscope. RESULTS: Ganglion cell layer showed significant increase in thickness in the BDL group (P<0.05). This increase was eliminated in the group where BDL rats received daily intraperitoneal injection of naltrexone hydrochloride (20 mg/kg). No other histological changes were detected in the other 5 layers we measured CONCLUSION: The morphological change we detected In the retina of cirrhotic rats is probably due to opioids increased tone in cirrhosis since the increase in thickness in the ganglion cell layer was almost eliminated when naltrexone hydrochloride was injected. These results suggest a possible role for endogenous opioids in the morphological retinal changes detected In cirrhotic rats.
- 18 August 2015
- Vol. 8  (4) , 681-684
Cirrhosis-induced morphological changes in the retina: possible role of endogenous opioid
AIM: To investigate the impact of cirrhosis on retinal morphology and to evaluate the role of endogenous opioids as a mediator in cirrhosis induced retinal change. METHODS: Thirty -six male rats were divided into 3 main groups; the common bile duct ligated (BDL) group, the sham -operated (Sham) group and the unoperated (Unop) group. Then each of these three main groups was divided into two subgroups; the first subgroup received daily injection of naltrexone hydrochloride (NIX) and the second group was injected with normal saline (Saline) daily. After 28d, rats were anesthetized and their right eyes were enucleated and assessed for histological changes. The thickness of the rod and cons layer, outer nuclear layer, outer plexiform layer, inner nuclear layer, Inner plexiform layer and ganglion cell layer for each eye were measured in micrometers by light microscope. RESULTS: Ganglion cell layer showed significant increase in thickness in the BDL group (P<0.05). This increase was eliminated in the group where BDL rats received daily intraperitoneal injection of naltrexone hydrochloride (20 mg/kg). No other histological changes were detected in the other 5 layers we measured CONCLUSION: The morphological change we detected In the retina of cirrhotic rats is probably due to opioids increased tone in cirrhosis since the increase in thickness in the ganglion cell layer was almost eliminated when naltrexone hydrochloride was injected. These results suggest a possible role for endogenous opioids in the morphological retinal changes detected In cirrhotic rats.
- Open Access
- 20 May 2015
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 10  (2)
Vitamin E and Omega-3, 6 and 9 Combinations Versus Vitamin E in the Treatment of Mastodynia
Background;: Breast pain or mastodynia is moderate to severe pain, which affects around 22 - 41% of women. If no anomaly is found and other causes, like nutritional changes, are excluded, many drugs, including herbal supplements, are recommended for the treatment of mastodynia. Objectives: This study was performed to evaluate the effects of vitamin E and omega-3, 6 and 9 free fatty acids combinations versus Vitamin E in women with mastodynia. Patients and Methods: A double blind, randomized clinical trial was conducted in Shohada Ashayer Hospital in Khorramabad Lorestan province, in the vest of Iran. A total of 88 women with symptoms of mastodynia, aged between 20 - 55 years old, were divided to two groups. The patients were randomly assigned to receive vitamin E (400 U/day) and vitamin E (400 U/day) plus omega-3, 6 and 9 (1200 mg/day) orally, for 3 months. Results: Vitamin E plus omega free fatty acids are more effective than the use of vitamin E alone in decreasing mastodynia. Significant difference was seen between the Cardiff Breast Score (CBS) of the vitamin E group compared to vitamin E - omega group (P < 0.05) at the end of the first, second and third months after treatment. Conclusions: Our results showed that vitamin E plus omega free fatty acids decrease the severity of mastodynia better than vitamin E alone. Keywords: Mastodynia; Vitamin E; Omega-3 Fatty Acids; Omega-6 Fatty Acids
- 20 May 2015
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 10  (2)
Open AccessVitamin E and Omega-3, 6 and 9 Combinations Versus Vitamin E in the Treatment of Mastodynia
Background;: Breast pain or mastodynia is moderate to severe pain, which affects around 22 - 41% of women. If no anomaly is found and other causes, like nutritional changes, are excluded, many drugs, including herbal supplements, are recommended for the treatment of mastodynia. Objectives: This study was performed to evaluate the effects of vitamin E and omega-3, 6 and 9 free fatty acids combinations versus Vitamin E in women with mastodynia. Patients and Methods: A double blind, randomized clinical trial was conducted in Shohada Ashayer Hospital in Khorramabad Lorestan province, in the vest of Iran. A total of 88 women with symptoms of mastodynia, aged between 20 - 55 years old, were divided to two groups. The patients were randomly assigned to receive vitamin E (400 U/day) and vitamin E (400 U/day) plus omega-3, 6 and 9 (1200 mg/day) orally, for 3 months. Results: Vitamin E plus omega free fatty acids are more effective than the use of vitamin E alone in decreasing mastodynia. Significant difference was seen between the Cardiff Breast Score (CBS) of the vitamin E group compared to vitamin E - omega group (P < 0.05) at the end of the first, second and third months after treatment. Conclusions: Our results showed that vitamin E plus omega free fatty acids decrease the severity of mastodynia better than vitamin E alone. Keywords: Mastodynia; Vitamin E; Omega-3 Fatty Acids; Omega-6 Fatty Acids
- 14 February 2015
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 40  (4) , 1204-1209
Effect of olive leaf, Satureja khuzestanica, and Allium sativum extracts on Giardia lamblia cysts compared with metronidazole in vitro
Giardia lamblia is one of the common causes of worldwide diarrhea in children. Appropriate medicinal treatment for giardiasis is available but there are some evidences of drug resistance, insufficient efficacy, and unpleasant side effects. In order to reach a more natural drug with suitable efficacy and the lowest side effects, the effects of the hydroalcoholic extracts of olive leaf, Satureja khuzestanica, and Allium sativum on G. lamblia cysts were evaluated in vitro, as well as antigiardial effect of the extracts was compared with metronidazole as the drug of choice. 2 and 5 mg of the plants extracts and powder of metronidazole 250 mg pills were added to 1 ml of G. lamblia cysts suspension (containing 5,000 cyst/ml normal saline), and the percentages of bioavailability of G. lamblia cysts were examined at the 2nd and 4th h after exposure and in 4 and 37 °C temperatures using eosin 0.1 % and a haemocytometer. The data were analyzed by multiway ANOVA test, Tukey’s test, and the SPSS software, version 18. The examinations demonstrated that olive leaf extract had the most fatality rate on G. lamblia cysts in vitro (37.90 ± 7.01 %), followed by the extract of S. khuzestanica (32.52 ± 9.07 %). Metronidazole 250 mg pills had relatively effective fatality rate on G. lamblia cysts in vitro (28.75 ± 10.30 %), whereas A. sativum (garlic) had the lowest fatality effect on G. lamblia cysts in vitro (22.65 ± 10.47 %). With respect to higher fatality effect of olive leaf and S. khuzestanica extracts compared with metronidazole in vitro, these plants can be used as suitable candidates to make new antigiardial drugs with low side effects and without drug resistance in the treatment of giardiasis in children.
- 14 February 2015
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 40  (4) , 1204-1209
Effect of olive leaf, Satureja khuzestanica, and Allium sativum extracts on Giardia lamblia cysts compared with metronidazole in vitro
Giardia lamblia is one of the common causes of worldwide diarrhea in children. Appropriate medicinal treatment for giardiasis is available but there are some evidences of drug resistance, insufficient efficacy, and unpleasant side effects. In order to reach a more natural drug with suitable efficacy and the lowest side effects, the effects of the hydroalcoholic extracts of olive leaf, Satureja khuzestanica, and Allium sativum on G. lamblia cysts were evaluated in vitro, as well as antigiardial effect of the extracts was compared with metronidazole as the drug of choice. 2 and 5 mg of the plants extracts and powder of metronidazole 250 mg pills were added to 1 ml of G. lamblia cysts suspension (containing 5,000 cyst/ml normal saline), and the percentages of bioavailability of G. lamblia cysts were examined at the 2nd and 4th h after exposure and in 4 and 37 °C temperatures using eosin 0.1 % and a haemocytometer. The data were analyzed by multiway ANOVA test, Tukey’s test, and the SPSS software, version 18. The examinations demonstrated that olive leaf extract had the most fatality rate on G. lamblia cysts in vitro (37.90 ± 7.01 %), followed by the extract of S. khuzestanica (32.52 ± 9.07 %). Metronidazole 250 mg pills had relatively effective fatality rate on G. lamblia cysts in vitro (28.75 ± 10.30 %), whereas A. sativum (garlic) had the lowest fatality effect on G. lamblia cysts in vitro (22.65 ± 10.47 %). With respect to higher fatality effect of olive leaf and S. khuzestanica extracts compared with metronidazole in vitro, these plants can be used as suitable candidates to make new antigiardial drugs with low side effects and without drug resistance in the treatment of giardiasis in children.
- Open Access
- 22 January 2015
- Published by SAGE Publications in Journal of Evidence-Based Complementary & Alternative Medicine
- Vol. 20  (3) , 173-179
Identifying Effective Medicinal Plants for Cold in Lorestan Province, West of Iran
Cold is a kind of mild and self-limiting viral illness that is considered as a prevalent disease with global occurrence and is caused by more than 200 types of viruses. Ethnobotanical studies and the use traditional experiences have increased the probability of detecting effective medicinal substances for cold by 40%. This study aimed to identify effective medicinal plants for cold in Lorestan province. Traditional medical information of this work was obtained from information from indigenous people in 8 cities of Lorestan province. A previously prepared questionnaire was given to trained health liaisons to record the people’s beliefs about the plants. The results showed that 23 medicinal plants were used in Lorestan province for treating cold and its symptoms (cough, sore throat, sneezing, runny nose, etc). Plants studied in this article contained bioactive substances that are recommended as the most popular traditional treatments. More research studies should be done on the efficacy and the potential harms of medicinal plants used by people, and in the case of their positive pharmacological impacts, they can be used to produce natural and effective drugs for cold.
- 22 January 2015
- Published by SAGE Publications in Journal of Evidence-Based Complementary & Alternative Medicine
- Vol. 20  (3) , 173-179
Open AccessIdentifying Effective Medicinal Plants for Cold in Lorestan Province, West of Iran
Cold is a kind of mild and self-limiting viral illness that is considered as a prevalent disease with global occurrence and is caused by more than 200 types of viruses. Ethnobotanical studies and the use traditional experiences have increased the probability of detecting effective medicinal substances for cold by 40%. This study aimed to identify effective medicinal plants for cold in Lorestan province. Traditional medical information of this work was obtained from information from indigenous people in 8 cities of Lorestan province. A previously prepared questionnaire was given to trained health liaisons to record the people’s beliefs about the plants. The results showed that 23 medicinal plants were used in Lorestan province for treating cold and its symptoms (cough, sore throat, sneezing, runny nose, etc). Plants studied in this article contained bioactive substances that are recommended as the most popular traditional treatments. More research studies should be done on the efficacy and the potential harms of medicinal plants used by people, and in the case of their positive pharmacological impacts, they can be used to produce natural and effective drugs for cold.
- 10 September 2014
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 70  (3) , 837-847
The plant histaminase: a promising enzyme with antioxidant properties versus histamine release in isoprenaline-induced myocardial infarction in rats
The present study was designed to evaluate possible protective effects of purified histaminase from Lathyrus sativus L. seedling on the myocardial injuries upon isoprenaline-induced myocardial infarction in rats. In this regard, blood histamine concentration, creatine kinase-MB (CK-MB) activity, antioxidant status, and histopathological changes of the hearts were measured. A total of 40 adult male Sprague–Dawley rats were divided into five equal groups and treated in the following order: control (normal saline), isoprenaline (isoproterenol 110 mg/kg BW), Isopren.-H1 (isoprenaline plus histaminase 80 U/kg BW), Isopren.-H2 (isoprenaline plus histaminase 120 U/kg BW), and Isopren.-H3 (isoprenaline plus histaminase 160 U/kg BW). Myocardial infarction was manifested by a significant elevation in the level of CK-MB and histopathological findings in isoprenaline group when compared to controls. In contrast, histaminase pretreatment at dose of 160 U/kg prevented isoprenaline-induced histamine release and significantly decreased CK-MB activity as well as histopathological changes in Isopren.-H3 group. A significant increase in the catalase (CAT) and superoxide dismutase (SOD) activities was also observed by histaminase treatment in Isopren.-H2 and Isopren.-H3 groups. Although the activity of glutathione peroxidase (GPx) increased significantly to suppress oxidative stress in isoprenaline group, it was not able to prevent lipid peroxidation (as shown by TBARS concentration) in the heart of rats. In conclusion, the plant-originated histaminase presented as a promising enzyme with antioxidant properties against histamine release and myocardial infarction in rats, and it seems be a suitable therapeutic agent for future clinical trials in humans.
- 10 September 2014
- Published by Springer Nature in Journal of Physiology and Biochemistry
- Vol. 70  (3) , 837-847
The plant histaminase: a promising enzyme with antioxidant properties versus histamine release in isoprenaline-induced myocardial infarction in rats
The present study was designed to evaluate possible protective effects of purified histaminase from Lathyrus sativus L. seedling on the myocardial injuries upon isoprenaline-induced myocardial infarction in rats. In this regard, blood histamine concentration, creatine kinase-MB (CK-MB) activity, antioxidant status, and histopathological changes of the hearts were measured. A total of 40 adult male Sprague–Dawley rats were divided into five equal groups and treated in the following order: control (normal saline), isoprenaline (isoproterenol 110 mg/kg BW), Isopren.-H1 (isoprenaline plus histaminase 80 U/kg BW), Isopren.-H2 (isoprenaline plus histaminase 120 U/kg BW), and Isopren.-H3 (isoprenaline plus histaminase 160 U/kg BW). Myocardial infarction was manifested by a significant elevation in the level of CK-MB and histopathological findings in isoprenaline group when compared to controls. In contrast, histaminase pretreatment at dose of 160 U/kg prevented isoprenaline-induced histamine release and significantly decreased CK-MB activity as well as histopathological changes in Isopren.-H3 group. A significant increase in the catalase (CAT) and superoxide dismutase (SOD) activities was also observed by histaminase treatment in Isopren.-H2 and Isopren.-H3 groups. Although the activity of glutathione peroxidase (GPx) increased significantly to suppress oxidative stress in isoprenaline group, it was not able to prevent lipid peroxidation (as shown by TBARS concentration) in the heart of rats. In conclusion, the plant-originated histaminase presented as a promising enzyme with antioxidant properties against histamine release and myocardial infarction in rats, and it seems be a suitable therapeutic agent for future clinical trials in humans.